Smith Asset Management Group LP

SEC CIK: 0001091561
Latest filing: Aug 6, 2021

SEC filings (opens in a new tab)

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by Smith Asset Management Group LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overview All 13F holders of BBIO Full Q2 2021 holdings

Shares (Q2 2021): 100
Value: $6.00K
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2021

Holdings of BBIO by Smith Asset Management Group LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	100	$6.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	100	$6.00K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.